Underlying Mechanism of Jiuwei Shengmai Powder in Improving Myocardial Hypoxia at High Altitude Based on Network Pharmacology and Molecular Docking

ABSTRACT Background High altitude shock is attributed to myocardial ischemia and hypoxia. Jiuwei Shengmai powder has positive impacts on human physiology. However, it is unknown if it can mitigate myocardial ischemia and hypoxia. This study aimed to postulate the molecular mechanism that relieves my...

Full description

Saved in:
Bibliographic Details
Main Authors: Cong Wu, Yanjuan Zhu, Changpeng Xie, Haobo Liu, Yuanming Pan, Chang'e Liu
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:iLabmed
Subjects:
Online Access:https://doi.org/10.1002/ila2.70011
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849392088760713216
author Cong Wu
Yanjuan Zhu
Changpeng Xie
Haobo Liu
Yuanming Pan
Chang'e Liu
author_facet Cong Wu
Yanjuan Zhu
Changpeng Xie
Haobo Liu
Yuanming Pan
Chang'e Liu
author_sort Cong Wu
collection DOAJ
description ABSTRACT Background High altitude shock is attributed to myocardial ischemia and hypoxia. Jiuwei Shengmai powder has positive impacts on human physiology. However, it is unknown if it can mitigate myocardial ischemia and hypoxia. This study aimed to postulate the molecular mechanism that relieves myocardial hypoxia injury in officers and soldiers at high altitude after ingesting Jiuwei Shengmai powder by using network pharmacology and molecular docking. Methods The effective components and potential targets of Jiuwei Shengmai powder were detected by databases such as the traditional Chinese medicine systems pharmacology (TCMSP), PubChem, and UniProt. Target genes related to myocardial hypoxia injury were identified using Gene Cards, Online Mendelian Inheritance in Man, DrugBank, DisGeNET, the Comparative Toxicogenomics Database, and other databases. CytoScape was used to construct a “drug‐active ingredient‐target gene” network. Protein‐protein interactions (PPIs) were predicted using the STRING database. Core gene target data were analyzed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment utilizing R packages, while Autodock Vina was used to verify the molecular docking simulation. Results One hundred and sixteen active ingredients were identified in Jiuwei Shengmai powder and were shown to target 197 genes. Of these, 3073 core target genes were related to myocardial hypoxia injury, and 130 core genes were obtained after Veen intersection. There were 129 PPI nodes and 1769 edges. The docking binding energy was ≤ −5.0 kcal·mol−1, indicating strong binding between the active compounds and targets. Quercetin and kaempferol are the main components in Jiuwei Shengmai powder that relieve myocardial hypoxia injury. Their core targets are interleukin‐6 and activated cysteine proteinase‐3 antibody, which are mainly related to PI3K‐Akt‐, mitogen‐activated protein kinase (MAPK), tumor necrosis factor (TNF), and interleukin 17 (IL‐17) signaling pathways. Conclusions This study provides a strong theoretical basis to understand the interaction of the components in Jiuwei Shengmai powder with human genes and proteins that should help to plan biochemical studies to better understand myocardial hypoxia injury mitigation.
format Article
id doaj-art-748d511a4dad4751992cbd3e2abca70f
institution Kabale University
issn 2834-443X
2834-4448
language English
publishDate 2025-06-01
publisher Wiley
record_format Article
series iLabmed
spelling doaj-art-748d511a4dad4751992cbd3e2abca70f2025-08-20T03:40:50ZengWileyiLabmed2834-443X2834-44482025-06-013223023910.1002/ila2.70011Underlying Mechanism of Jiuwei Shengmai Powder in Improving Myocardial Hypoxia at High Altitude Based on Network Pharmacology and Molecular DockingCong Wu0Yanjuan Zhu1Changpeng Xie2Haobo Liu3Yuanming Pan4Chang'e Liu5Department of Nutrition The Seventh Medical Center of Chinese PLA General Hospital Beijing ChinaDepartment of Intensive Care Medicine Pediatric Medicine The Seventh Medical Center of Chinese PLA General Hospital Beijing ChinaDepartment of Basic Medical Sciences Medical College Qinghai University Xining ChinaCollege of Medicine Inner Mongolia Medical University Hohhot ChinaCancer Research Center Beijing Chest Hospital Capital Medical University, Beijing Tuberculosis & Thoracic Tumor Research Institute Beijing ChinaDepartment of Nutrition The Seventh Medical Center of Chinese PLA General Hospital Beijing ChinaABSTRACT Background High altitude shock is attributed to myocardial ischemia and hypoxia. Jiuwei Shengmai powder has positive impacts on human physiology. However, it is unknown if it can mitigate myocardial ischemia and hypoxia. This study aimed to postulate the molecular mechanism that relieves myocardial hypoxia injury in officers and soldiers at high altitude after ingesting Jiuwei Shengmai powder by using network pharmacology and molecular docking. Methods The effective components and potential targets of Jiuwei Shengmai powder were detected by databases such as the traditional Chinese medicine systems pharmacology (TCMSP), PubChem, and UniProt. Target genes related to myocardial hypoxia injury were identified using Gene Cards, Online Mendelian Inheritance in Man, DrugBank, DisGeNET, the Comparative Toxicogenomics Database, and other databases. CytoScape was used to construct a “drug‐active ingredient‐target gene” network. Protein‐protein interactions (PPIs) were predicted using the STRING database. Core gene target data were analyzed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment utilizing R packages, while Autodock Vina was used to verify the molecular docking simulation. Results One hundred and sixteen active ingredients were identified in Jiuwei Shengmai powder and were shown to target 197 genes. Of these, 3073 core target genes were related to myocardial hypoxia injury, and 130 core genes were obtained after Veen intersection. There were 129 PPI nodes and 1769 edges. The docking binding energy was ≤ −5.0 kcal·mol−1, indicating strong binding between the active compounds and targets. Quercetin and kaempferol are the main components in Jiuwei Shengmai powder that relieve myocardial hypoxia injury. Their core targets are interleukin‐6 and activated cysteine proteinase‐3 antibody, which are mainly related to PI3K‐Akt‐, mitogen‐activated protein kinase (MAPK), tumor necrosis factor (TNF), and interleukin 17 (IL‐17) signaling pathways. Conclusions This study provides a strong theoretical basis to understand the interaction of the components in Jiuwei Shengmai powder with human genes and proteins that should help to plan biochemical studies to better understand myocardial hypoxia injury mitigation.https://doi.org/10.1002/ila2.70011Jiuwei Shengmai powdermolecular dockingmyocardial hypoxia injurynetwork pharmacologyplateau troops
spellingShingle Cong Wu
Yanjuan Zhu
Changpeng Xie
Haobo Liu
Yuanming Pan
Chang'e Liu
Underlying Mechanism of Jiuwei Shengmai Powder in Improving Myocardial Hypoxia at High Altitude Based on Network Pharmacology and Molecular Docking
iLabmed
Jiuwei Shengmai powder
molecular docking
myocardial hypoxia injury
network pharmacology
plateau troops
title Underlying Mechanism of Jiuwei Shengmai Powder in Improving Myocardial Hypoxia at High Altitude Based on Network Pharmacology and Molecular Docking
title_full Underlying Mechanism of Jiuwei Shengmai Powder in Improving Myocardial Hypoxia at High Altitude Based on Network Pharmacology and Molecular Docking
title_fullStr Underlying Mechanism of Jiuwei Shengmai Powder in Improving Myocardial Hypoxia at High Altitude Based on Network Pharmacology and Molecular Docking
title_full_unstemmed Underlying Mechanism of Jiuwei Shengmai Powder in Improving Myocardial Hypoxia at High Altitude Based on Network Pharmacology and Molecular Docking
title_short Underlying Mechanism of Jiuwei Shengmai Powder in Improving Myocardial Hypoxia at High Altitude Based on Network Pharmacology and Molecular Docking
title_sort underlying mechanism of jiuwei shengmai powder in improving myocardial hypoxia at high altitude based on network pharmacology and molecular docking
topic Jiuwei Shengmai powder
molecular docking
myocardial hypoxia injury
network pharmacology
plateau troops
url https://doi.org/10.1002/ila2.70011
work_keys_str_mv AT congwu underlyingmechanismofjiuweishengmaipowderinimprovingmyocardialhypoxiaathighaltitudebasedonnetworkpharmacologyandmoleculardocking
AT yanjuanzhu underlyingmechanismofjiuweishengmaipowderinimprovingmyocardialhypoxiaathighaltitudebasedonnetworkpharmacologyandmoleculardocking
AT changpengxie underlyingmechanismofjiuweishengmaipowderinimprovingmyocardialhypoxiaathighaltitudebasedonnetworkpharmacologyandmoleculardocking
AT haoboliu underlyingmechanismofjiuweishengmaipowderinimprovingmyocardialhypoxiaathighaltitudebasedonnetworkpharmacologyandmoleculardocking
AT yuanmingpan underlyingmechanismofjiuweishengmaipowderinimprovingmyocardialhypoxiaathighaltitudebasedonnetworkpharmacologyandmoleculardocking
AT changeliu underlyingmechanismofjiuweishengmaipowderinimprovingmyocardialhypoxiaathighaltitudebasedonnetworkpharmacologyandmoleculardocking